pharmaceutical industry - st. john's university plc (nyse:agn), headquartered in dublin,...

8
In partnership with FELLOWSHIP PROGRAM SAINT JOHN’S UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES 2016 - 2017 PHARMACEUTICAL INDUSTRY

Upload: vuanh

Post on 26-Mar-2018

215 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

In partnership with

FELLOWSHIP PROGRAMSAINT JOHN’S UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES2016 - 2017

PHARMACEUTICAL INDUSTRY

Email: [email protected]

Additional information visit: www.stjohns.edu/academics/schools-and-colleges/college-pharmacy-and-health-sciences/residency-and-fellowship-programs

ELIGIBILITY REQUIREMENTSTo be considered for the St. John’s University/Allergan Pharmaceutical Industry

Fellowship Program, you must meet the following requirements:

• Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited

Doctor of Pharmacy Program prior to the start of the fellowship term

• Have a strong interest in pursuing a career in the pharmaceutical industry

Interviews begin Sunday, December 4th, 2016 at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas, NV.

APPLICATION PROCESS

SEND ELECTRONIC COPIES TO:Dr. Joseph Brocavich: [email protected].

SJU Allergan Fellows: [email protected]

NYSE:AGN | www.Allergan.com

© 2016 Allergan. ® Marks owned by Allergan. All rights reserved

D E A D L I N E S Curriculum Vitae

December 13, 2016

Letter of Intent December 13, 2016

O� cial College Transcript December 13, 2016

Letters of Recommendation (3) December 16, 2016

*does not have to include the fall semester grades

Page 2: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Allergan plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in

a new industry model - Growth Pharma. Our company is focused on developing, manufacturing and commercializing

branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio

of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and

dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutic categories.

We are an industry leader in research and development, with one of the broadest innovative

development pipelines in the pharmaceutical industry with 65+ mid-to-late stage pipeline

programs in development. With commercial operations in approximately

100 countries, our company is committed to working with physicians,

healthcare providers and patients to deliver innovative

and meaningful treatments to help people around the

world live longer, healthier lives.

Learn more at www.Allergan.com

ABOUT OUR COMPANY

OUR WORLD-CLASS MANUFACTURING AND R&D NETWORK

Fellowship Program 2016 - 2017

USAFall River, MA

Cincinnati, OH

Northern, CA (Biologics)

Irvine, CA (Biologics)

Waco, TX

Jersey City, NJ

Rockaway, NJ

Bridgewater, NJ

Irvine, CA

COSTA RICAHeredia, San Jose

BRAZILGuarulhos

IRELANDWestport

Clonshaugh, Dublin

Westport

BELGIUMLiege

GERMANYWeiterstadt

FRANCEPringy

Pringy

MANUFACTURING

CHINABeijing

Shanghai

JAPANTokyo

UKLiverpool

Marlow

R&D

SINGAPORESingapore

Fellowship Program 2016 - 2017

ST. JOHN’S UNIVERSITY COMPONENT Fellows are full-time University employees and are provided a competitive stipend and benefi ts package, including

comprehensive health insurance. Each Fellow is required to complete a one-semester teaching component at the

University during their fi rst year and a collaborative research project by the end of the second year.

Additionally, each Fellow is able to participate in a number of other professional and educational development

opportunities at the University, including precepting pharmacy students; continuing education courses; resident

and fellow seminars; A� liate Faculty appointments; and a teaching certifi cate course. Fellows may also enroll and

participate in University courses and graduate degree programs.

CERTIFICATE OF COMPLETIONUpon successful completion of the program, Fellows receive a certifi cate from St. John’s University College of

Pharmacy and Health Sciences and Allergan.

WEBSITE: www.stjohns.edu/academics/schools-and-colleges/college-pharmacy-and-health-sciences

ABOUT OUR SCHOOL

Donna Sym, BS, PharmDFELLOWSHIP COORDINATOR ASSOCIATE PROFESSOR/INDUSTRY PROFESSIONAL “The St. John’s University College of Pharmacy and Health Sciences and the Allergan Fellowship strives to provide Doctor of Pharmacy graduates with the highest level of training, experience, and education to promote placement in leadership positions”

LOCATION: Queens, NY

DEAN: Russell J. DiGate, Ph.D.

GRADUATE PROGRAMS OFFERED:

• M.S./Ph.D. in Pharmaceutical Sciences;

• M.S. in Biological and Pharmaceutical Biotechnology, Pharmacy Administration,

and Toxicology• Masters of Business Administration (MBA)

• Master of Public Health (MPH)

St. John’s University College of Pharmacy and Health Sciences, located in Queens, NY, is a� liated

and partners with a number of elite healthcare organizations throughout the New York metropolitan

area. Founded in 1929, the University o� ers undergraduate and graduate level healthcare-related

programs. Undergraduates and graduates are actively involved in basic science, clinical research,

and providing patient-centered care to an urban patient population.

1 2

Page 3: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Allergan plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in

a new industry model - Growth Pharma. Our company is focused on developing, manufacturing and commercializing

branded pharmaceuticals, devices and biologic products for patients around the world. Allergan markets a portfolio

of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and

dermatology, gastroenterology, women’s health, urology, and anti-infective therapeutic categories.

We are an industry leader in research and development, with one of the broadest innovative

development pipelines in the pharmaceutical industry with 65+ mid-to-late stage pipeline

programs in development. With commercial operations in approximately

100 countries, our company is committed to working with physicians,

healthcare providers and patients to deliver innovative

and meaningful treatments to help people around the

world live longer, healthier lives.

Learn more at www.Allergan.com

ABOUT OUR COMPANY

OUR WORLD-CLASS MANUFACTURING AND R&D NETWORK

Fellowship Program 2016 - 2017

USAFall River, MA

Cincinnati, OH

Northern, CA (Biologics)

Irvine, CA (Biologics)

Waco, TX

Jersey City, NJ

Rockaway, NJ

Bridgewater, NJ

Irvine, CA

COSTA RICAHeredia, San Jose

BRAZILGuarulhos

IRELANDWestport

Clonshaugh, Dublin

Westport

BELGIUMLiege

GERMANYWeiterstadt

FRANCEPringy

Pringy

MANUFACTURING

CHINABeijing

Shanghai

JAPANTokyo

UKLiverpool

Marlow

R&D

SINGAPORESingapore

Fellowship Program 2016 - 2017

ST. JOHN’S UNIVERSITY COMPONENT Fellows are full-time University employees and are provided a competitive stipend and benefi ts package, including

comprehensive health insurance. Each Fellow is required to complete a one-semester teaching component at the

University during their fi rst year and a collaborative research project by the end of the second year.

Additionally, each Fellow is able to participate in a number of other professional and educational development

opportunities at the University, including precepting pharmacy students; continuing education courses; resident

and fellow seminars; A� liate Faculty appointments; and a teaching certifi cate course. Fellows may also enroll and

participate in University courses and graduate degree programs.

CERTIFICATE OF COMPLETIONUpon successful completion of the program, Fellows receive a certifi cate from St. John’s University College of

Pharmacy and Health Sciences and Allergan.

WEBSITE: www.stjohns.edu/academics/schools-and-colleges/college-pharmacy-and-health-sciences

ABOUT OUR SCHOOL

Donna Sym, BS, PharmDFELLOWSHIP COORDINATOR ASSOCIATE PROFESSOR/INDUSTRY PROFESSIONAL “The St. John’s University College of Pharmacy and Health Sciences and the Allergan Fellowship strives to provide Doctor of Pharmacy graduates with the highest level of training, experience, and education to promote placement in leadership positions”

LOCATION: Queens, NY

DEAN: Russell J. DiGate, Ph.D.

GRADUATE PROGRAMS OFFERED:

• M.S./Ph.D. in Pharmaceutical Sciences;

• M.S. in Biological and Pharmaceutical Biotechnology, Pharmacy Administration,

and Toxicology• Masters of Business Administration (MBA)

• Master of Public Health (MPH)

St. John’s University College of Pharmacy and Health Sciences, located in Queens, NY, is a� liated

and partners with a number of elite healthcare organizations throughout the New York metropolitan

area. Founded in 1929, the University o� ers undergraduate and graduate level healthcare-related

programs. Undergraduates and graduates are actively involved in basic science, clinical research,

and providing patient-centered care to an urban patient population.

1 2

Page 4: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Fellowship Program 2016 - 2017 Fellowship Program 2016 - 2017

Our Global Regulatory Strategy team leads our Company’s business-critical relationships with the U.S. Food

and Drug Administration (FDA) and other global regulatory agencies throughout the world, ensuring the

continued success of our product portfolio and pipeline.

GLOBAL REGULATORY STRATEGY FELLOW ACTIVITIES• Supporting the development, fi ling, and regulatory approval of new products

• Filing and maintaining Investigational New Drug Applications (INDs) and New Drug Applications (NDAs)

• Ensuring team compliance with all appropriate federal regulations and guidances

Amjad Iqbal, PharmDGLOBAL REGULATORY STRATEGY FELLOW 2004-2006 “The St. John’s/Allergan Industry Fellowship gave me the skill sets necessary to achieve a successful career in the pharmaceutical industry. The fast-paced, high-energy environment, paired with a very dedicated group of preceptors, a� orded me a customized learning experience that provided the confi dence necessary to seek high-profi le challenging, and rewarding positions in the industry.”

• Clinical Development

• Global Drug Safety

• Global Monitoring Operations

• Health Economics and Outcomes Research

• Marketing

• Medical A� airs

• New Products Market Research

Our Clinical Development team is responsible for the development and execution of our global Phase II - IV clinical

trials across our therapeutic categories.

CLINICAL DEVELOPMENT FELLOW ACTIVITIES• Participating in the conceptualization, conduct and management of clinical trials

• Developing study protocols, informed consent forms, fi nal study reports and other clinical trial materials

• Training and managing investigative sites

• Analyzing, interpreting, and reporting clinical trial data

• New Products Scientifi c Assessment

• Project Management

• Quality Assurance/Compliance

• Global Regulatory Strategy

• Regulatory A� airs Advertising and Labeling

• External rotations with the FDA are also permitted

The Global Regulatory Strategy and Clinical Development fellowships o� er the opportunity for fellows to rotate to

other functional areas during their second year, helping to accelerate their professional growth and broaden their

industry experience. Possible second-year rotations (3-12 months in duration) include, but are not limited to:

SECOND YEAR ROTATIONGLOBAL REGULATORY STRATEGY FELLOWSHIP

ABOUT OUR FELLOWSHIPNow entering its 14th year, the St. John’s University/ Allergan Fellowship Program (formerly known

as the Actavis/ Forest Research Institute Fellowship) is one of the most dynamic and challenging

development programs in the industry. In partnership with St. John’s University College of Pharmacy

and Health Sciences, we o� er three 2-year fellowships focused in Global Regulatory Strategy,

Clinical Development and Regulatory A� airs Advertising and Labeling. The programs are based in

our New Jersey o� ce and are designed to o� er a broad range of hands-on training and professional

development opportunities.

CLINICAL DEVELOPMENT FELLOWSHIP

3 4

Page 5: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Fellowship Program 2016 - 2017 Fellowship Program 2016 - 2017

Our Global Regulatory Strategy team leads our Company’s business-critical relationships with the U.S. Food

and Drug Administration (FDA) and other global regulatory agencies throughout the world, ensuring the

continued success of our product portfolio and pipeline.

GLOBAL REGULATORY STRATEGY FELLOW ACTIVITIES• Supporting the development, fi ling, and regulatory approval of new products

• Filing and maintaining Investigational New Drug Applications (INDs) and New Drug Applications (NDAs)

• Ensuring team compliance with all appropriate federal regulations and guidances

Amjad Iqbal, PharmDGLOBAL REGULATORY STRATEGY FELLOW 2004-2006 “The St. John’s/Allergan Industry Fellowship gave me the skill sets necessary to achieve a successful career in the pharmaceutical industry. The fast-paced, high-energy environment, paired with a very dedicated group of preceptors, a� orded me a customized learning experience that provided the confi dence necessary to seek high-profi le challenging, and rewarding positions in the industry.”

• Clinical Development

• Global Drug Safety

• Global Monitoring Operations

• Health Economics and Outcomes Research

• Marketing

• Medical A� airs

• New Products Market Research

Our Clinical Development team is responsible for the development and execution of our global Phase II - IV clinical

trials across our therapeutic categories.

CLINICAL DEVELOPMENT FELLOW ACTIVITIES• Participating in the conceptualization, conduct and management of clinical trials

• Developing study protocols, informed consent forms, fi nal study reports and other clinical trial materials

• Training and managing investigative sites

• Analyzing, interpreting, and reporting clinical trial data

• New Products Scientifi c Assessment

• Project Management

• Quality Assurance/Compliance

• Global Regulatory Strategy

• Regulatory A� airs Advertising and Labeling

• External rotations with the FDA are also permitted

The Global Regulatory Strategy and Clinical Development fellowships o� er the opportunity for fellows to rotate to

other functional areas during their second year, helping to accelerate their professional growth and broaden their

industry experience. Possible second-year rotations (3-12 months in duration) include, but are not limited to:

SECOND YEAR ROTATIONGLOBAL REGULATORY STRATEGY FELLOWSHIP

ABOUT OUR FELLOWSHIPNow entering its 14th year, the St. John’s University/ Allergan Fellowship Program (formerly known

as the Actavis/ Forest Research Institute Fellowship) is one of the most dynamic and challenging

development programs in the industry. In partnership with St. John’s University College of Pharmacy

and Health Sciences, we o� er three 2-year fellowships focused in Global Regulatory Strategy,

Clinical Development and Regulatory A� airs Advertising and Labeling. The programs are based in

our New Jersey o� ce and are designed to o� er a broad range of hands-on training and professional

development opportunities.

CLINICAL DEVELOPMENT FELLOWSHIP

3 4

Page 6: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Fellowship Program 2016 - 2017 Fellowship Program 2016 - 2017

Our Regulatory A� airs Advertising and Labeling team is responsible for liaising with Regulatory agencies (e.g., FDA’s

O� ce of Prescription Drug Promotion) related to advertising, promotion, and labeling.

REGULATORY AFFAIRS-ADVERTISING AND LABELING FELLOW ACTIVITIES• Providing Allergan’s internal stakeholders with strategic regulatory advice on advertising and promotional materials,

in accordance with FDA regulations and business goals.

• Facilitating the creation, revision, and maintenance of product labeling so that it provides accurate product

information to health care providers and consumers.

• Gaining comprehensive knowledge of advertising and labeling regulations

• Applying regulations to the development of product advertising (including, but not limited to, TV and print

advertising), promotion, and drug labeling.

REGULATORY ADVERTISING & PROMOTION REGULATORY LABELING MARKETING ROTATION OF CHOICE REGULATORY ADVERTISING & PROMOTION

9 months 3 months 3 months 3 months 6 months

REGULATORY AFFAIRS - ADVERTISING AND LABELING FELLOWSHIP SCHEDULE

CURRENT FELLOWS

Erika Culotta, PharmDSt. John’s University, College of

Pharmacy and Health Sciences,

Clinical Development Fellow

2016-2018

Colin Vechery, PharmDDuquesne University,

Mylan School of Pharmacy,

Global Regulatory Strategy

Fellow 2015 - 2017

Erica L Gray, BS, PharmDDuquesne University,

Mylan School of Pharmacy,

Clinical Development Fellow

2015 - 2017

Daanish Ashraf, PharmDUniversity of Illinois at Chicago,

College of Pharmacy,

Global Regulatory Strategy Fellow

2016-2018

Betsy Kurian, PharmDAssociate Director, Regulatory A� airs, NovartisSt. John’s University, College of Pharmacy and Health Sciences

CLINICAL DEVELOPMENT

Yunji Kim, PharmDSenior Manager, Regulatory A� airs, Regeneron PharmaceuticalsUniversity of North Carolina at Chapel Hill,Eshelman School of Pharmacy

Donato M. Forlenza, PharmD, MBA Associate Director, Regulatory A� airs Advertising and Promotion Compliance, Boehringer Ingelheim PharmaceuticalsAlbany College of Pharmacy and Health Sciences

Jessica Kachadourian, PharmDAssociate Director, Medical A� airs NovartisNortheastern University

Julie Plotnikov, PharmDProduct Manager LEO Pharma A/STemple University School of Pharmacy

Rachel Luchini, PharmDSenior Manager, Clinical DevelopmentAllergan PLC.Rutgers University, Ernest Mario School of Pharmacy

Sejal P. Emerson, PharmDDirector, Regulatory A� airs AbbVieUniversity of Michigan, College of Pharmacy

Kerri Z. Kaplan, PharmDAssociate Director, Regulatory A� airsAllergan PLC.Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences

Shweta Pandya, PharmD Senior Manager, Regulatory A� airs, Advertising and Promotion, Allergan PLC.St. John’s University, College of Pharmacy and Allied Health Professions

Peter J. McFarland, PharmDMedical Science Liaison, Teva PharmaceuticalsMassachusetts College of Pharmacy and Health Sciences

Hiren D. Patel, PharmD, MS, RAC USPHSTeam Leader, Regulatory Health Project Management Division of Psychiatry Products Center For Drug Evaluation & Research, FDASt. John’s University, College of Pharmacy and Allied Health Professions

Vincent C. Yan, PharmDSenior Product Manager, Gilead SciencesRutgers University, Ernest Mario School of Pharmacy

Amjad Iqbal, PharmDSenior Director, Regulatory A� airs, Allergan PLC.University of Cincinnati, College of Pharmacy

Joseph P. Stalder, PharmDDirector of Product Management, Achaogen University of California, San Diego

Nicole L. Bradley, PharmDDirector, Regulatory A� airs, Allergan PLC.The Ohio State University

Karen A. Allen, PharmDManager, Quality Assurance GCP GLP PVDaiichi Sankyo, Inc.St. John’s University, College of Pharmacy and Allied Health Professions

Hilary Winters Henshaw, PharmDRegulatory Program DirectorProduct Development, GenentechUniversity of Michigan, College of Pharmacy

Michael C. Camuso, PharmDSenior Pharmacist, Investigational Drug Services, Boston Medical CenterAlbany College of Pharmacy and Health Sciences

Amol J. Parekh, PharmDManager, Regulatory A� airs NovartisRutgers University, Ernest Mario School of Pharmacy

Maxwell Adams, PharmDClinical Research Scientist, Allergan PLCMassachusetts College of Pharmacy and Health Sciences

PAST FELLOWS

2005 - 2007

2008 - 2010

2011 - 2013

2006 - 2008

2009 - 2011

2012 - 2014

2007 - 2009

2010 - 2012

2013 - 2015

2004 - 2006

YEARS

REGULATORY AFFAIRS–ADVERTISING AND LABELING FELLOWSHIP

GLOBAL REGULATORY STRATEGY

Francis Nguyen, PharmDUniversity of Maryland School

of Pharmacy, Regulatory A� airs -

Advertising & Labeling Fellow

2016-2018

Reena NadparaManager, Global Regulatory Strategy, Allergan PLCRutgers University, Ernest Mario School of Pharmacy

Omar KhalidManager, Regulatory A� airs, Biogen St. John’s University, College of Pharmacy and Health Sciences

2014 - 2016

5 6

Page 7: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

Fellowship Program 2016 - 2017 Fellowship Program 2016 - 2017

Our Regulatory A� airs Advertising and Labeling team is responsible for liaising with Regulatory agencies (e.g., FDA’s

O� ce of Prescription Drug Promotion) related to advertising, promotion, and labeling.

REGULATORY AFFAIRS-ADVERTISING AND LABELING FELLOW ACTIVITIES• Providing Allergan’s internal stakeholders with strategic regulatory advice on advertising and promotional materials,

in accordance with FDA regulations and business goals.

• Facilitating the creation, revision, and maintenance of product labeling so that it provides accurate product

information to health care providers and consumers.

• Gaining comprehensive knowledge of advertising and labeling regulations

• Applying regulations to the development of product advertising (including, but not limited to, TV and print

advertising), promotion, and drug labeling.

REGULATORY ADVERTISING & PROMOTION REGULATORY LABELING MARKETING ROTATION OF CHOICE REGULATORY ADVERTISING & PROMOTION

9 months 3 months 3 months 3 months 6 months

REGULATORY AFFAIRS - ADVERTISING AND LABELING FELLOWSHIP SCHEDULE

CURRENT FELLOWS

Erika Culotta, PharmDSt. John’s University, College of

Pharmacy and Health Sciences,

Clinical Development Fellow

2016-2018

Colin Vechery, PharmDDuquesne University,

Mylan School of Pharmacy,

Global Regulatory Strategy

Fellow 2015 - 2017

Erica L Gray, BS, PharmDDuquesne University,

Mylan School of Pharmacy,

Clinical Development Fellow

2015 - 2017

Daanish Ashraf, PharmDUniversity of Illinois at Chicago,

College of Pharmacy,

Global Regulatory Strategy Fellow

2016-2018

Betsy Kurian, PharmDAssociate Director, Regulatory A� airs, NovartisSt. John’s University, College of Pharmacy and Health Sciences

CLINICAL DEVELOPMENT

Yunji Kim, PharmDSenior Manager, Regulatory A� airs, Regeneron PharmaceuticalsUniversity of North Carolina at Chapel Hill,Eshelman School of Pharmacy

Donato M. Forlenza, PharmD, MBA Associate Director, Regulatory A� airs Advertising and Promotion Compliance, Boehringer Ingelheim PharmaceuticalsAlbany College of Pharmacy and Health Sciences

Jessica Kachadourian, PharmDAssociate Director, Medical A� airs NovartisNortheastern University

Julie Plotnikov, PharmDProduct Manager LEO Pharma A/STemple University School of Pharmacy

Rachel Luchini, PharmDSenior Manager, Clinical DevelopmentAllergan PLC.Rutgers University, Ernest Mario School of Pharmacy

Sejal P. Emerson, PharmDDirector, Regulatory A� airs AbbVieUniversity of Michigan, College of Pharmacy

Kerri Z. Kaplan, PharmDAssociate Director, Regulatory A� airsAllergan PLC.Long Island University, Arnold & Marie Schwartz College of Pharmacy and Health Sciences

Shweta Pandya, PharmD Senior Manager, Regulatory A� airs, Advertising and Promotion, Allergan PLC.St. John’s University, College of Pharmacy and Allied Health Professions

Peter J. McFarland, PharmDMedical Science Liaison, Teva PharmaceuticalsMassachusetts College of Pharmacy and Health Sciences

Hiren D. Patel, PharmD, MS, RAC USPHSTeam Leader, Regulatory Health Project Management Division of Psychiatry Products Center For Drug Evaluation & Research, FDASt. John’s University, College of Pharmacy and Allied Health Professions

Vincent C. Yan, PharmDSenior Product Manager, Gilead SciencesRutgers University, Ernest Mario School of Pharmacy

Amjad Iqbal, PharmDSenior Director, Regulatory A� airs, Allergan PLC.University of Cincinnati, College of Pharmacy

Joseph P. Stalder, PharmDDirector of Product Management, Achaogen University of California, San Diego

Nicole L. Bradley, PharmDDirector, Regulatory A� airs, Allergan PLC.The Ohio State University

Karen A. Allen, PharmDManager, Quality Assurance GCP GLP PVDaiichi Sankyo, Inc.St. John’s University, College of Pharmacy and Allied Health Professions

Hilary Winters Henshaw, PharmDRegulatory Program DirectorProduct Development, GenentechUniversity of Michigan, College of Pharmacy

Michael C. Camuso, PharmDSenior Pharmacist, Investigational Drug Services, Boston Medical CenterAlbany College of Pharmacy and Health Sciences

Amol J. Parekh, PharmDManager, Regulatory A� airs NovartisRutgers University, Ernest Mario School of Pharmacy

Maxwell Adams, PharmDClinical Research Scientist, Allergan PLCMassachusetts College of Pharmacy and Health Sciences

PAST FELLOWS

2005 - 2007

2008 - 2010

2011 - 2013

2006 - 2008

2009 - 2011

2012 - 2014

2007 - 2009

2010 - 2012

2013 - 2015

2004 - 2006

YEARS

REGULATORY AFFAIRS–ADVERTISING AND LABELING FELLOWSHIP

GLOBAL REGULATORY STRATEGY

Francis Nguyen, PharmDUniversity of Maryland School

of Pharmacy, Regulatory A� airs -

Advertising & Labeling Fellow

2016-2018

Reena NadparaManager, Global Regulatory Strategy, Allergan PLCRutgers University, Ernest Mario School of Pharmacy

Omar KhalidManager, Regulatory A� airs, Biogen St. John’s University, College of Pharmacy and Health Sciences

2014 - 2016

5 6

Page 8: PHARMACEUTICAL INDUSTRY - St. John's University plc (NYSE:AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model - Growth

In partnership with

FELLOWSHIP PROGRAMSAINT JOHN’S UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES2016 - 2017

PHARMACEUTICAL INDUSTRY

Email: [email protected]

Additional information visit: www.stjohns.edu/academics/schools-and-colleges/college-pharmacy-and-health-sciences/residency-and-fellowship-programs

ELIGIBILITY REQUIREMENTSTo be considered for the St. John’s University/Allergan Pharmaceutical Industry

Fellowship Program, you must meet the following requirements:

• Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited

Doctor of Pharmacy Program prior to the start of the fellowship term

• Have a strong interest in pursuing a career in the pharmaceutical industry

Interviews begin Sunday, December 4th, 2016 at the American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas, NV.

APPLICATION PROCESS

SEND ELECTRONIC COPIES TO:Dr. Joseph Brocavich: [email protected].

SJU Allergan Fellows: [email protected]

NYSE:AGN | www.Allergan.com

© 2016 Allergan. ® Marks owned by Allergan. All rights reserved

D E A D L I N E S Curriculum Vitae

December 13, 2016

Letter of Intent December 13, 2016

O� cial College Transcript December 13, 2016

Letters of Recommendation (3) December 16, 2016

*does not have to include the fall semester grades